相关实验视频

Updated: Jun 3, 2025

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration

Published on: September 29, 2018

在自身脂肪衍生干细胞中IL-6表达升高调节了骨关节炎中RANKL介导的炎症

Hyun-Joo Lee¹, Dae-Yong Kim^1,2, Hyeon Jeong Noh^1,2

¹Stem Cell R&D Center, N-BIOTEK, Inc., 104-706, Technopark Ssangyong 3Cha, 397, Seokcheon-ro, Bucheon-si 14449, Republic of Korea.

|January 8, 2025

概括

高表达脂肪衍生干细胞 (ASCs) 的高IL-6 (IL-6) 显示增强的免疫调节和减少核因子卡帕-β连接体 (RANKL) 受体激活器表达. 这表明ASC中的IL-6水平可以通过控制炎症和软骨退化来优化骨关节炎 (OA) 治疗.

科学领域:

免疫学免疫学免疫学
再生医学是一种再生医学.
整形外科整形外科整形外科

背景情况:

介酶干细胞 (MSCs),包括脂肪基干细胞 (ASCs),在软骨再生和免疫反应中发挥作用.
骨关节炎 (OA) 涉及退行性过程和炎症,其中免疫因子如INTERLEUQIN-6 (IL-6) 和核因子Kappa-Β连接体 (RANKL) 的受体激活器是关键的.
在OA治疗中,ASCs的精确免疫调节机制,特别是关于IL-6和RANKL,需要进一步阐明.

研究的目的:

研究OA患者自身ASC中的IL-6表达与其免疫调节能力之间的关系.
评估IL-6水平对RANKL调节的影响,RANKL是OA软骨退化的关键媒介.
评估IL-6表达作为选择ASCs用于增强性OA治疗的生物标志物的潜力.

主要方法:

自主性ASC从22名OA患者中分离出来,并进行了表征.
根据IL-6水平,ASC被分为高IL-6表达和低IL-6表达组.
用激活的外周血液单核细胞 (PBMC) 进行共同培养实验,以评估免疫调节功能 (Treg诱导,免疫细胞增殖,细胞因子产生).
在两个ASC组中测量了RANKL表达.

主要成果:

与低IL-6ASC相比,高IL-6表达的ASC显示显著增强了免疫细胞增殖和干扰素- (IFN-γ) 生产的抑制.
具有高IL-6表达的ASC显着减少了RANKL表达.
这些发现表明,较高的IL-6水平与改善的免疫调节和抗骨质结晶性潜力之间存在相关性.

结论:

自主性ASC中IL-6的高表达与增强的免疫调节特性和通过RANKL抑制减少骨质结晶发生有关.
根据IL-6表达水平选择ASC可能会提高OA治疗的治疗疗效.
这种方法可以减轻免疫驱动的关节炎症和软骨退化,可能减缓OA的进展.

关键词:

自体脂肪衍生的干细胞 (ASCs).互白素-6 (IL-6) 是一种蛋白质.骨关节炎 (OA) 是一种核因子卡帕-Β连接体 (RANKL) 的受体激活剂

更多相关视频

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Isolation and Enrichment of Human Adipose-derived Stromal Cells for Enhanced Osteogenesis

Isolation and Enrichment of Human Adipose-derived Stromal Cells for Enhanced Osteogenesis

Published on: January 12, 2015

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...